Genetic dissection of the biosynthetic route to gentamicin A2 by heterologous expression of its minimal gene set

Je Won Park, Jay Sung Joong Hong, Niranjan Parajuli, Seok Jung Won, Ryeol Park Sung, Si Kyu Lim, Kyung Sohng Jae, Joon Yoon Yeo

Research output: Contribution to journalArticle

41 Citations (Scopus)

Abstract

Since the first use of streptomycin as an effective antibiotic drug in the treatment of tuberculosis, aminoglycoside antibiotics have been widely used against a variety of bacterial infections for over six decades. However, the pathways for aminoglycoside biosynthesis still remain unclear, mainly because of difficulty in genetic manipulation of actinomycetes producing this class of antibiotics. Gentamicin belongs to the group of 4,6-disubstituted aminoglycosides containing a characteristic core aminocyclitol moiety, 2-deoxystreptamine (2-DOS), and the recent discovery of its biosynthetic gene cluster in Micromonospora echinospora has enabled us to decipher its biosynthetic pathway. To determine the minimal set of genes and their functions for the generation of gentamicin A2, the first pseudotrisaccharide intermediate in the biosynthetic pathway for the gentamicin complex, various sets of candidate genes from M. echinospora and other related aminoglycoside-producing strains were introduced into a nonaminoglycoside producing strain of Streptomyces venezuelae. Heterologous expression of different combinations of putative 2-DOS biosynthetic genes revealed that a subset, gtmB-gtmA-gacH, is responsible for the biosynthesis of this core aminocyclitol moiety of gentamicin. Expression of gtmG together with gtmB-gtmA-gacH led to production of 2′-N-acetylparomamine, demonstrating that GtmG acts as a glycosyltransferase that adds N-acetyl-D-glucosamine (GLcNA) to 2-DOS. Expression of gtmM in a 2′-N-acetylparomamine-producing recombinant S. venezuelae strain generated paromamine. Expression of gtmE in an engineered paromamine-producing strain of S. venezuelae successfully generated gentamicin A2, indicating that GtmE is another glycosyltransferase that attaches D-xylose to paromamine. These results represent in vivo evidence elucidating the complete biosynthetic pathway of the pseudotrisaccharide aminoglycoside.

Original languageEnglish
Pages (from-to)8399-8404
Number of pages6
JournalProceedings of the National Academy of Sciences of the United States of America
Volume105
Issue number24
DOIs
Publication statusPublished - 2008 Jun 17
Externally publishedYes

Fingerprint

Aminoglycosides
Gentamicins
varespladib methyl
Dissection
Biosynthetic Pathways
Glycosyltransferases
Genes
Anti-Bacterial Agents
Micromonospora
Acetylglucosamine
Actinobacteria
Xylose
Streptomyces
Streptomycin
Multigene Family
Bacterial Infections
Tuberculosis
Pharmaceutical Preparations
paromamine
2-deoxystreptamine

Keywords

  • Aminoglycoside biosynthesis
  • Micromonospora echinospora
  • Pathway engineering
  • Streptomyces venezuelae

ASJC Scopus subject areas

  • General

Cite this

Genetic dissection of the biosynthetic route to gentamicin A2 by heterologous expression of its minimal gene set. / Park, Je Won; Hong, Jay Sung Joong; Parajuli, Niranjan; Won, Seok Jung; Sung, Ryeol Park; Lim, Si Kyu; Jae, Kyung Sohng; Yeo, Joon Yoon.

In: Proceedings of the National Academy of Sciences of the United States of America, Vol. 105, No. 24, 17.06.2008, p. 8399-8404.

Research output: Contribution to journalArticle

Park, Je Won ; Hong, Jay Sung Joong ; Parajuli, Niranjan ; Won, Seok Jung ; Sung, Ryeol Park ; Lim, Si Kyu ; Jae, Kyung Sohng ; Yeo, Joon Yoon. / Genetic dissection of the biosynthetic route to gentamicin A2 by heterologous expression of its minimal gene set. In: Proceedings of the National Academy of Sciences of the United States of America. 2008 ; Vol. 105, No. 24. pp. 8399-8404.
@article{36dd6c2ecf194b22b507f5fb395a05bd,
title = "Genetic dissection of the biosynthetic route to gentamicin A2 by heterologous expression of its minimal gene set",
abstract = "Since the first use of streptomycin as an effective antibiotic drug in the treatment of tuberculosis, aminoglycoside antibiotics have been widely used against a variety of bacterial infections for over six decades. However, the pathways for aminoglycoside biosynthesis still remain unclear, mainly because of difficulty in genetic manipulation of actinomycetes producing this class of antibiotics. Gentamicin belongs to the group of 4,6-disubstituted aminoglycosides containing a characteristic core aminocyclitol moiety, 2-deoxystreptamine (2-DOS), and the recent discovery of its biosynthetic gene cluster in Micromonospora echinospora has enabled us to decipher its biosynthetic pathway. To determine the minimal set of genes and their functions for the generation of gentamicin A2, the first pseudotrisaccharide intermediate in the biosynthetic pathway for the gentamicin complex, various sets of candidate genes from M. echinospora and other related aminoglycoside-producing strains were introduced into a nonaminoglycoside producing strain of Streptomyces venezuelae. Heterologous expression of different combinations of putative 2-DOS biosynthetic genes revealed that a subset, gtmB-gtmA-gacH, is responsible for the biosynthesis of this core aminocyclitol moiety of gentamicin. Expression of gtmG together with gtmB-gtmA-gacH led to production of 2′-N-acetylparomamine, demonstrating that GtmG acts as a glycosyltransferase that adds N-acetyl-D-glucosamine (GLcNA) to 2-DOS. Expression of gtmM in a 2′-N-acetylparomamine-producing recombinant S. venezuelae strain generated paromamine. Expression of gtmE in an engineered paromamine-producing strain of S. venezuelae successfully generated gentamicin A2, indicating that GtmE is another glycosyltransferase that attaches D-xylose to paromamine. These results represent in vivo evidence elucidating the complete biosynthetic pathway of the pseudotrisaccharide aminoglycoside.",
keywords = "Aminoglycoside biosynthesis, Micromonospora echinospora, Pathway engineering, Streptomyces venezuelae",
author = "Park, {Je Won} and Hong, {Jay Sung Joong} and Niranjan Parajuli and Won, {Seok Jung} and Sung, {Ryeol Park} and Lim, {Si Kyu} and Jae, {Kyung Sohng} and Yeo, {Joon Yoon}",
year = "2008",
month = "6",
day = "17",
doi = "10.1073/pnas.0803164105",
language = "English",
volume = "105",
pages = "8399--8404",
journal = "Proceedings of the National Academy of Sciences of the United States of America",
issn = "0027-8424",
number = "24",

}

TY - JOUR

T1 - Genetic dissection of the biosynthetic route to gentamicin A2 by heterologous expression of its minimal gene set

AU - Park, Je Won

AU - Hong, Jay Sung Joong

AU - Parajuli, Niranjan

AU - Won, Seok Jung

AU - Sung, Ryeol Park

AU - Lim, Si Kyu

AU - Jae, Kyung Sohng

AU - Yeo, Joon Yoon

PY - 2008/6/17

Y1 - 2008/6/17

N2 - Since the first use of streptomycin as an effective antibiotic drug in the treatment of tuberculosis, aminoglycoside antibiotics have been widely used against a variety of bacterial infections for over six decades. However, the pathways for aminoglycoside biosynthesis still remain unclear, mainly because of difficulty in genetic manipulation of actinomycetes producing this class of antibiotics. Gentamicin belongs to the group of 4,6-disubstituted aminoglycosides containing a characteristic core aminocyclitol moiety, 2-deoxystreptamine (2-DOS), and the recent discovery of its biosynthetic gene cluster in Micromonospora echinospora has enabled us to decipher its biosynthetic pathway. To determine the minimal set of genes and their functions for the generation of gentamicin A2, the first pseudotrisaccharide intermediate in the biosynthetic pathway for the gentamicin complex, various sets of candidate genes from M. echinospora and other related aminoglycoside-producing strains were introduced into a nonaminoglycoside producing strain of Streptomyces venezuelae. Heterologous expression of different combinations of putative 2-DOS biosynthetic genes revealed that a subset, gtmB-gtmA-gacH, is responsible for the biosynthesis of this core aminocyclitol moiety of gentamicin. Expression of gtmG together with gtmB-gtmA-gacH led to production of 2′-N-acetylparomamine, demonstrating that GtmG acts as a glycosyltransferase that adds N-acetyl-D-glucosamine (GLcNA) to 2-DOS. Expression of gtmM in a 2′-N-acetylparomamine-producing recombinant S. venezuelae strain generated paromamine. Expression of gtmE in an engineered paromamine-producing strain of S. venezuelae successfully generated gentamicin A2, indicating that GtmE is another glycosyltransferase that attaches D-xylose to paromamine. These results represent in vivo evidence elucidating the complete biosynthetic pathway of the pseudotrisaccharide aminoglycoside.

AB - Since the first use of streptomycin as an effective antibiotic drug in the treatment of tuberculosis, aminoglycoside antibiotics have been widely used against a variety of bacterial infections for over six decades. However, the pathways for aminoglycoside biosynthesis still remain unclear, mainly because of difficulty in genetic manipulation of actinomycetes producing this class of antibiotics. Gentamicin belongs to the group of 4,6-disubstituted aminoglycosides containing a characteristic core aminocyclitol moiety, 2-deoxystreptamine (2-DOS), and the recent discovery of its biosynthetic gene cluster in Micromonospora echinospora has enabled us to decipher its biosynthetic pathway. To determine the minimal set of genes and their functions for the generation of gentamicin A2, the first pseudotrisaccharide intermediate in the biosynthetic pathway for the gentamicin complex, various sets of candidate genes from M. echinospora and other related aminoglycoside-producing strains were introduced into a nonaminoglycoside producing strain of Streptomyces venezuelae. Heterologous expression of different combinations of putative 2-DOS biosynthetic genes revealed that a subset, gtmB-gtmA-gacH, is responsible for the biosynthesis of this core aminocyclitol moiety of gentamicin. Expression of gtmG together with gtmB-gtmA-gacH led to production of 2′-N-acetylparomamine, demonstrating that GtmG acts as a glycosyltransferase that adds N-acetyl-D-glucosamine (GLcNA) to 2-DOS. Expression of gtmM in a 2′-N-acetylparomamine-producing recombinant S. venezuelae strain generated paromamine. Expression of gtmE in an engineered paromamine-producing strain of S. venezuelae successfully generated gentamicin A2, indicating that GtmE is another glycosyltransferase that attaches D-xylose to paromamine. These results represent in vivo evidence elucidating the complete biosynthetic pathway of the pseudotrisaccharide aminoglycoside.

KW - Aminoglycoside biosynthesis

KW - Micromonospora echinospora

KW - Pathway engineering

KW - Streptomyces venezuelae

UR - http://www.scopus.com/inward/record.url?scp=46149125940&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=46149125940&partnerID=8YFLogxK

U2 - 10.1073/pnas.0803164105

DO - 10.1073/pnas.0803164105

M3 - Article

VL - 105

SP - 8399

EP - 8404

JO - Proceedings of the National Academy of Sciences of the United States of America

JF - Proceedings of the National Academy of Sciences of the United States of America

SN - 0027-8424

IS - 24

ER -